These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14610621)

  • 1. A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.
    Card KF; Price-Schiavi SA; Liu B; Thomson E; Nieves E; Belmont H; Builes J; Jiao JA; Hernandez J; Weidanz J; Sherman L; Francis JL; Amirkhosravi A; Wong HC
    Cancer Immunol Immunother; 2004 Apr; 53(4):345-57. PubMed ID: 14610621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein.
    Belmont HJ; Price-Schiavi S; Liu B; Card KF; Lee HI; Han KP; Wen J; Tang S; Zhu X; Merrill J; Chavillaz PA; Wong JL; Rhode PR; Wong HC
    Clin Immunol; 2006 Oct; 121(1):29-39. PubMed ID: 16807113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
    J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
    Lev A; Novak H; Segal D; Reiter Y
    J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.
    Epel M; Carmi I; Soueid-Baumgarten S; Oh S; Bera T; Pastan I; Berzofsky J; Reiter Y
    Eur J Immunol; 2008 Jun; 38(6):1706-20. PubMed ID: 18446790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.
    Epel M; Ellenhorn JD; Diamond DJ; Reiter Y
    Cancer Immunol Immunother; 2002 Nov; 51(10):565-73. PubMed ID: 12384808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
    Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
    J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo characterization of a novel antibody-like single-chain TCR human IgG1 fusion protein.
    Mosquera LA; Card KF; Price-Schiavi SA; Belmont HJ; Liu B; Builes J; Zhu X; Chavaillaz PA; Lee HI; Jiao JA; Francis JL; Amirkhosravi A; Wong RL; Wong HC
    J Immunol; 2005 Apr; 174(7):4381-8. PubMed ID: 15778403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting activity of a TCR/IL-2 fusion protein against established tumors.
    Wen J; Zhu X; Liu B; You L; Kong L; Lee HI; Han KP; Wong JL; Rhode PR; Wong HC
    Cancer Immunol Immunother; 2008 Dec; 57(12):1781-94. PubMed ID: 18369620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.
    Ma Q; Garber HR; Lu S; He H; Tallis E; Ding X; Sergeeva A; Wood MS; Dotti G; Salvado B; Ruisaard K; Clise-Dwyer K; John LS; Rezvani K; Alatrash G; Shpall EJ; Molldrem JJ
    Cytotherapy; 2016 Aug; 18(8):985-994. PubMed ID: 27265873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of p53(264-272)/HLA-A*0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor.
    Zhu X; Belmont HJ; Price-Schiavi S; Liu B; Lee HI; Fernandez M; Wong RL; Builes J; Rhode PR; Wong HC
    J Immunol; 2006 Mar; 176(5):3223-32. PubMed ID: 16493083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific roles of each TCR hemichain in generating functional chain-centric TCR.
    Nakatsugawa M; Yamashita Y; Ochi T; Tanaka S; Chamoto K; Guo T; Butler MO; Hirano N
    J Immunol; 2015 Apr; 194(7):3487-500. PubMed ID: 25710913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies.
    Fishman MN; Thompson JA; Pennock GK; Gonzalez R; Diez LM; Daud AI; Weber JS; Huang BY; Tang S; Rhode PR; Wong HC
    Clin Cancer Res; 2011 Dec; 17(24):7765-75. PubMed ID: 21994418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death.
    Wittman VP; Woodburn D; Nguyen T; Neethling FA; Wright S; Weidanz JA
    J Immunol; 2006 Sep; 177(6):4187-95. PubMed ID: 16951384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.
    Denkberg G; Cohen CJ; Lev A; Chames P; Hoogenboom HR; Reiter Y
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9421-6. PubMed ID: 12093904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
    Wang Z; Turner R; Baker BM; Biddison WE
    J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire.
    Alters SE; Gadea JR; Sorich M; O'Donoghue G; Talib S; Philip R
    J Immunother; 1998 Jan; 21(1):17-26. PubMed ID: 9456432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
    Li D; Bentley C; Anderson A; Wiblin S; Cleary KLS; Koustoulidou S; Hassanali T; Yates J; Greig J; Nordkamp MO; Trenevska I; Ternette N; Kessler BM; Cornelissen B; Cragg MS; Banham AH
    Cancer Res; 2017 May; 77(10):2699-2711. PubMed ID: 28363997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.